HAL (France)open access
Systematic Management of a Critical CYP3A4 Interaction Between Cabozantinib and Carbamazepine: A Case Report of a Clinically Relevant Pharmacokinetic Interaction
Drug–drug interaction, Adverse effects, Tyrosine kinase inhibitor, Cabozantinib, 0, Drug-drug interaction, 1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 464350
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.